A carregar...
Progress in Immunotherapy for Non-small Cell Lung Cancer
In recent years, the five-year survival rate of patients with advanced stage non-small cell lung cancer (NSCLC) remains low despite recent advances in surgery, irradiation, chemotherapy, and targeted therapy. Immunotherapy which utilizes the immune system to control and eradicate cancer is a viable...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Chinês |
Publicado em: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2014-01-01
|
Colecção: | Chinese Journal of Lung Cancer |
Assuntos: | |
Acesso em linha: | http://dx.doi.org/10.3779/j.issn.1009-3419.2014.01.06 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|